We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.16B
AUM Growth
-$821M
Cap. Flow
-$392M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$145M
2
ASML icon
ASML
ASML
+$119M
3
QRVO icon
Qorvo
QRVO
+$89M
4
MSFT icon
Microsoft
MSFT
+$82.9M
5
ISRG icon
Intuitive Surgical
ISRG
+$75.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.56%
2 Technology 29.01%
3 Industrials 8.79%
4 Communication Services 5.99%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBAC
226
DELISTED
RedBall Acquisition Corp.
RBAC
$5.96M 0.1%
600,000
DSAC
227
DELISTED
Duddell Street Acquisition Corp. Class A Ordinary Shares
DSAC
$5.96M 0.1%
600,000
EJFA
228
DELISTED
EJF Acquisition Corp. Class A Ordinary Share
EJFA
$5.93M 0.1%
599,999
+145,845
+32% +$1.44M
PASG icon
229
Passage Bio
PASG
$14.1M
$5.93M 0.1%
95,694
-57
-0.1% -$4.7K
HCIC
230
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$5.89M 0.1%
600,002
WOOF icon
231
Petco
WOOF
$791M
$5.88M 0.1%
300,636
-188,154
-38% -$3.52M
AGGR
232
DELISTED
Agile Growth Corp
AGGR
$5.87M 0.1%
599,999
HD icon
233
Home Depot
HD
$349B
$5.84M 0.09%
19,506
-42,894
-69% -$14.9M
PRGO icon
234
Perrigo
PRGO
$1.74B
$5.83M 0.09%
151,639
HCP
235
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$5.7M 0.09%
105,600
-106,990
-50% -$6.22M
WOLF icon
236
Wolfspeed
WOLF
$1.43B
$5.63M 0.09%
49,448
-72,163
-59% -$7.27M
UL icon
237
Unilever
UL
$137B
$5.38M 0.09%
+105,009
New +$5.84M
COUP
238
DELISTED
Coupa Software Incorporated
COUP
$5.36M 0.09%
52,697
-69,066
-57% -$8.36M
ILMN icon
239
Illumina
ILMN
$29.3B
$5.34M 0.09%
15,709
-19,686
-56% -$6.65M
ALT icon
240
Altimmune
ALT
$585M
$5.16M 0.08%
846,618
+225,940
+36% +$1.66M
AMED
241
DELISTED
Amedisys
AMED
$5.15M 0.08%
+29,878
New +$4.46M
CCXI
242
DELISTED
ChemoCentryx, Inc.
CCXI
$5.09M 0.08%
203,093
+54,798
+37% +$1.54M
BLSA
243
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$5.06M 0.08%
512,616
AMLX icon
244
Amylyx Pharmaceuticals
AMLX
$2.69B
$5.01M 0.08%
+390,229
New +$8.81M
CGEM icon
245
Cullinan Oncology
CGEM
$1.1B
$4.97M 0.08%
475,058
AMBA icon
246
Ambarella
AMBA
$3.68B
$4.95M 0.08%
+47,160
New +$6.01M
REVHU
247
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$4.94M 0.08%
500,000
CVII
248
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$4.89M 0.08%
500,000
AAQC
249
DELISTED
Accelerate Acquisition Corp
AAQC
$4.88M 0.08%
500,000
PVLA
250
Palvella Therapeutics
PVLA
$2.23B
$4.81M 0.08%
19,843
-10,953
-36% -$2.88M

Similar funds

Woodline Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.

  • Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
  • Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
  • Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
  • Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
  • Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
  • Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.